110 related articles for article (PubMed ID: 27413883)
1. The Syndrome of Veno-occlusive Disease After Blood or Marrow Transplantation.
Carreras E; Rozman C
Hematology; 1998; 3(4):303-14. PubMed ID: 27413883
[TBL] [Abstract][Full Text] [Related]
2. Hepatic veno-occlusive disease--liver toxicity syndrome after bone marrow transplantation.
Shulman HM; Hinterberger W
Bone Marrow Transplant; 1992 Sep; 10(3):197-214. PubMed ID: 1422475
[TBL] [Abstract][Full Text] [Related]
3. Hepatic veno-occlusive disease after bone marrow transplant.
Carreras E; Grañena A; Rozman C
Blood Rev; 1993 Mar; 7(1):43-51. PubMed ID: 8467232
[TBL] [Abstract][Full Text] [Related]
4. Veno-occlusive disease (VOD) of the liver in Korean patients following allogeneic bone marrow transplantation (BMT): efficacy of recombinant human tissue plasminogen activator (rt-PA) treatment.
Lee JH; Lee KH; Choi JS; Zang DY; Kim SB; Kim SW; Suh C; Lee JS; Kim WK; Lee YS; Kim SH
J Korean Med Sci; 1996 Apr; 11(2):118-26. PubMed ID: 8835758
[TBL] [Abstract][Full Text] [Related]
5. BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation.
Dignan FL; Wynn RF; Hadzic N; Karani J; Quaglia A; Pagliuca A; Veys P; Potter MN; ;
Br J Haematol; 2013 Nov; 163(4):444-57. PubMed ID: 24102514
[TBL] [Abstract][Full Text] [Related]
6. Phase II trial of heparin prophylaxis for veno-occlusive disease of the liver in children undergoing bone marrow transplantation.
Rosenthal J; Sender L; Secola R; Killen R; Millerick M; Murphy L; Cairo MS
Bone Marrow Transplant; 1996 Jul; 18(1):185-91. PubMed ID: 8832013
[TBL] [Abstract][Full Text] [Related]
7. The veno-occlusive disease of the liver.
Baron F; Deprez M; Beguin Y
Haematologica; 1997; 82(6):718-25. PubMed ID: 9499675
[TBL] [Abstract][Full Text] [Related]
8. Veno-occlusive disease of the liver after marrow transplantation: histological correlates of clinical signs and symptoms.
Shulman HM; Fisher LB; Schoch HG; Henne KW; McDonald GB
Hepatology; 1994 May; 19(5):1171-81. PubMed ID: 8175139
[TBL] [Abstract][Full Text] [Related]
9. Transjugular intrahepatic portosystemic shunt (TIPS) for severe veno-occlusive disease of the liver following bone marrow transplantation.
Azoulay D; Castaing D; Lemoine A; Hargreaves GM; Bismuth H
Bone Marrow Transplant; 2000 May; 25(9):987-92. PubMed ID: 10800068
[TBL] [Abstract][Full Text] [Related]
10. A comparison of clinical criteria for the diagnosis of veno-occlusive disease of the liver after bone marrow transplantation.
Blostein MD; Paltiel OB; Thibault A; Rybka WB
Bone Marrow Transplant; 1992 Nov; 10(5):439-43. PubMed ID: 1464007
[TBL] [Abstract][Full Text] [Related]
11. Malignancy-associated pulmonary veno-occlusive disease: report of a case following autologous bone marrow transplantation and review.
Salzman D; Adkins DR; Craig F; Freytes C; LeMaistre CF
Bone Marrow Transplant; 1996 Oct; 18(4):755-60. PubMed ID: 8899191
[TBL] [Abstract][Full Text] [Related]
12. Role of plasminogen activator inhibitor-1 (PAI-1) levels in the diagnosis of BMT-associated hepatic veno-occlusive disease and monitoring of subsequent therapy with defibrotide (DF).
Kaleelrahman M; Eaton JD; Leeming D; Bowyer K; Taberner D; Chang J; Scarffe JH; Chopra R
Hematology; 2003 Apr; 8(2):91-5. PubMed ID: 12745658
[TBL] [Abstract][Full Text] [Related]
13. Role of PGE1 to prevent veno-occlusive disease of the liver after bone marrow transplantation.
Gluckman E; Jolivet I; Scrobohaci ML; Devergie A; Traineau R; Bourdeau-Espérou H; Lehn P; Faure P; Drouet L
Nouv Rev Fr Hematol (1978); 1990; 32(1):1-3. PubMed ID: 2349075
[TBL] [Abstract][Full Text] [Related]
14. Veno-occlusive disease of the liver after allogeneic bone marrow transplantation in children with hematologic malignancies: incidence, onset time and risk factors.
Hasegawa S; Horibe K; Kawabe T; Kato K; Kojima S; Matsuyama T; Hirabayashi N
Bone Marrow Transplant; 1998 Dec; 22(12):1191-7. PubMed ID: 9894723
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for hepatic veno-occlusive disease following HLA-identical sibling bone marrow transplants for leukemia.
Rozman C; Carreras E; Qian C; Gale RP; Bortin MM; Rowlings PA; Ash RC; Champlin RE; Henslee-Downey PJ; Herzig RH; Hinterberger W; Klein JP; Prentice HG; Reiffers J; Zwaan FE; Horowitz MM
Bone Marrow Transplant; 1996 Jan; 17(1):75-80. PubMed ID: 8673059
[TBL] [Abstract][Full Text] [Related]
16. [Veno-occlusive disease after bone marrow transplantation: preventive effect of heparin].
Parquet N; Devergie A; Socié G; Ribaud P; Espérou H; Gluckman E
Ann Med Interne (Paris); 1997; 148(2):132-5. PubMed ID: 9238437
[TBL] [Abstract][Full Text] [Related]
17. Transjugular intrahepatic portosystemic shunt for the management of severe venoocclusive disease following bone marrow transplantation.
Fried MW; Connaghan DG; Sharma S; Martin LG; Devine S; Holland K; Zuckerman A; Kaufman S; Wingard J; Boyer TD
Hepatology; 1996 Sep; 24(3):588-91. PubMed ID: 8781329
[TBL] [Abstract][Full Text] [Related]
18. Laboratory markers of veno-occlusive disease in the course of bone marrow and subsequent liver transplantation.
Salat C; Holler E; Wolf C; Kolb HJ; Reinhardt B; Pihusch R; Krämling HJ; Heinemann V; Haller M; Hiller E
Bone Marrow Transplant; 1997 Mar; 19(5):487-90. PubMed ID: 9052916
[TBL] [Abstract][Full Text] [Related]
19. Risk-adjusted monitoring of veno-occlusive disease following Bayesian individualization of busulfan dosage for bone marrow transplantation in paediatrics.
Brice K; Valerie B; Claire G; Valerie M; Yves B; Gilles A; Nathalie B
Pharmacoepidemiol Drug Saf; 2008 Feb; 17(2):135-43. PubMed ID: 17952879
[TBL] [Abstract][Full Text] [Related]
20. Changes in hemostatic parameters in hepatic veno-occlusive disease following bone marrow transplantation.
Park YD; Yasui M; Yoshimoto T; Chayama K; Shimono T; Okamura T; Inoue M; Yumura-Yagi K; Kawa-Ha K
Bone Marrow Transplant; 1997 May; 19(9):915-20. PubMed ID: 9156266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
